CVR 43398210Private limited company (ApS)Anden udgivelse af software (582900)København NFounded 18 Jul 2022
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about TrialSync ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
0
CVR, 2025
Gross profit
146.3K
DKK, annual report 2023
Result
-33.7K
DKK, annual report 2023
Equity
6.3K
DKK, annual report 2023
PROBE Holding ApSCVR 43398075, 100% of capital and votes, until 30 Dec 2025
Johan Lauritsenuntil 24 Jun 2025
No current owner is registered.
CVR 43398075100% of capital and votes18 Jul 2022 to 30 Dec 2025
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Jun 2025, monthly: 0 employees, 0 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Oct 2024 | Nov 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 3 | 2 | 1 | 2 | 3 | 1 | 3 | 4 | 3 | 3 | 3 | 4 | 2 | 2 | 0 | 0 | 0 |
| FTE | 0 | 1 | 1 | 0 | 0 | 3 | 1 | 3 | 3 | 6 | 3 | 3 | 4 | 2 | 2 | 0 | 0 | 0 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest Jun 2025, published 21 Oct 2026.
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2023 |
|---|---|
| Gross profit | 146 |
| Operating profit | -41 |
| Result for the year | -34 |
| Equity | 6 |
| Total assets | 113 |
| Employees (average) | 1 |
| Credit metrics (Dandex calculations) | |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
2023 covers 17 months (18 Jul 2022 to 31 Dec 2023).
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2023
18 Jul 2022 to 31 Dec 2023, published 10 Jul 2024
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for TrialSync ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 40,000 | None | 40,000 | None | 40,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 17 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 17 Nov 2026.
6 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Binavne:
TrialSync DK ApS UNDER KONKURS
TrialSync EU ApS UNDER KONKURS
Konkursbehandlingen afsluttet 30.12.2025, virksomheden opløst
Konkursdekret afsagt 24.06.2025 af Sø- og Handelsrettens Skifteretsafdeling
Direktion:
Fratrådte:
Johan Lauritsen, den 24.06.2025.
Revision:
Vedtægter ændret: 05.08.2024
Nyt navn: TrialSync ApS
Nye binavne: TrialSync DK ApS, TrialSync EU ApS
Vedtægter ændret: 07.08.2023
Nyt navn: PROBE DK ApS
Ny adresse: Tagensvej 16A, 2200 København N
Stiftelsesdato: 18.07.2022.
Virkningsdato: 18.07.2022.
Seneste vedtægtsdato: 18.07.2022.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 43398075 J. Lauritsen Holding ApS, Valbyholm 17, 4. 5, 2500 Valby, den 18.07.2022.
Direktion:
Johan Lauritsen, den 18.07.2022.
Selskabet tegnes af en direktør.
Første regnskabsår:
18.07.2022 - 31.12.2023.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at udvikle en digital platform, der strømliner processer, herunder rekruttering af patienter relateret til kliniske forsøgsstudier.
P-number 1028423892Tagensvej 16, 2200 København N